Projects per year
Personal profile
Biography
Professor Eric Morand is a a physician-scientist and Dean of the Sub-Faculty of Clinical and Molecular Medicine. The Sub-Faculty of Clinical and Molecular Medicine encompasses all Monash University research and teaching activities that are in partnership with Monash Health, Victoria's largest health service. This includes the School of Clinical Sciences, Victorian Heart Institute, Monash Centre for Health Research Implementation, and the University's partnership with the Hudson Institute of Medical Research.
As a researcher, Professor Morand specialises in the study of systemic lupus erythematosus. He is founder of the Monash Lupus Clinic, Australia's largest research-grounded clinic for patients with SLE, a founding member of the Australian Lupus Registry & Biobank, and Chair of the Asia-Pacific Lupus Collaboration. His lab research has focussed on the biology of glucocorticoids in rheumatic disease, and his clinical research focuses on measurement, outcomes and endpoints in lupus.
He is a clinical rheumatologist, and Head of the Monash Health Rheumatology Unit, the largest in Australia.
Research interests
Professor Morand is a physician-scientist whose key interests are clinical outcome measurement and biological profiling in SLE, and the actions of glucocorticoid induced proteins on the immune system. Read more at https://www.monash.edu/medicine/scs/researchers/eric-morand .
His group has pioneered the development and validation of treat-to-target outcome measures in SLE, via the Asia-Pacific Lupus Collaboration, which with over 4,000 patients under study is among the largest cohorts of SLE patients ever assembled.
Biomarker studies in SLE are also a major focus, with thousands of samples linked to longitudinal clinical data archived in the Australian Lupus Registry & Biobank, headquartered at Monash.
His lab discovered the role in rheumatic disease of multiple important glucocorticoid-regulated proteins. Most recently his group defined the role of GILZ in RA, Th17 pathways, B cell activation, and lupus, and are working on exploiting its actions to develop a safe glucocorticoid mimic. His lab also works on innate immunity including the actions of the unique pro-inflammatory protein, MIF.
Clinical activities
Professor Morand is Head of Rheumatology, Monash Health. He works in clinics servicing lupus, rheumatoid arthritis, and complex rheumatology cases, and undertakes ward duty inpatient care in the largest service in the country.
Consulting
Advisory expertise and research collaboration experience with international biotech and Pharma companies.
Special interests include Lupus / SLE outcome measures, trials, translational research and biomarkers.
Community service
Professor Morand is a Board member of Rare Voices Australia, has served on the board of the Australian Rheumatology Association and is a member of the Scientific Advisory Board of the ARA Research Trust.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Systemic Lupus Erythematosus
- glucocorticoids
- Lupus
- SLE
- RA
- GILZ
- MIF
- Rheumatoid Arthritis
- Rheumatology
- outcome measures
- Clinical Trials
- Translational Research
- Cytokines
Network
-
Targeted regulatory T cells to treat type 1 diabetes
Ooi, J., Monk, J. & Morand, E.
Juvenile Diabetes Research Foundation (JDRF) (United States of America)
2/01/23 → 31/12/25
Project: Research
-
Retrospective analysis of T2T endpoint achievement in SLE
Morand, E. & Kandane-Rathnayake, R.
1/01/23 → 1/09/24
Project: Research
-
Targeted Regulatory T Cells to Treat SLE
Ooi, J., Faridi, P. & Morand, E.
United States Department of Defense (DOD)
1/09/22 → 31/08/25
Project: Research
-
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Petri, M., Bruce, I. N., Dörner, T., Tanaka, Y., Morand, E. F., Kalunian, K. C., Cardiel, M. H., Silk, M. E., Dickson, C. L., Meszaros, G., Zhang, L., Jia, B., Zhao, Y., McVeigh, C. J. & Mosca, M., Mar 2023, In: The Lancet. 401, 10381, p. 1011-1019 9 p.Research output: Contribution to journal › Article › Research › peer-review
7 Citations (Scopus) -
Clinical associations of cognitive dysfunction in systemic lupus erythematosus
Raghunath, S., Glikmann-Johnston, Y., Golder, V., Kandane-Rathnayake, R., Morand, E. F., Stout, J. C. & Hoi, A., 28 Feb 2023, In: Lupus Science and Medicine. 10, 1, 10 p., e000835.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patients
Yamashita, S., Katsumata, Y., Konda, N., Kandane-Rathnayake, R. K., Morand, E. F. & Harigai, M., May 2023, In: Modern Rheumatology. 33, 3, p. 517-524 8 p.Research output: Contribution to journal › Article › Research › peer-review
-
Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
Raghunath, S., Guymer, E., Glikmann-Johnston, Y., Golder, V., Kandane-Rathnayake, R. K., Morand, E. F., Stout, J. C. & Hoi, A., Jan 2023, In: Rheumatology. 62, 1, p. 190-199 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Frequency and clinical utility of antibodies to extractable nuclear antigen in the setting of a negative antinuclear antibody test
Yeo, A. L., Ojaimi, S., Le, S., Leech, M. & Morand, E., 2023, (Accepted/In press) In: Arthritis Care & Research. 7 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Prizes
-
Dean's Award for Research (Enterprise)
Morand, Eric (Recipient), 1 Aug 2018
Prize: Prize (including medals and awards)
-
Distinguished Innovator Award, Lupus Research Alliance
Morand, Eric (Recipient), 2015
Prize: National/international honour
-
Evelyn V Hess MD Award, Lupus Foundation of America
Morand, Eric (Recipient), 8 Nov 2022
Prize: Prize (including medals and awards)
-
Fellow of the Academy of Health and Medical Sciences
Morand, Eric (Recipient), 13 Oct 2022
Prize: Election to learned society
-
Activities
- 2 Editorial responsibility
-
The Lancet Rheumatology (Journal)
Eric Morand (Editorial board member)
1 Jan 2020 → …Activity: Publication peer-review and editorial work types › Editorial responsibility
-
Nature Reviews Rheumatology (Journal)
Eric Morand (Editorial board member)
2014Activity: Publication peer-review and editorial work types › Editorial responsibility